⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26894045 | 0.81 | — | — | |
| SCHEMBL16142226 | 0.79 | TSHR (0.48) | — | |
| SCHEMBL19006928 | 0.72 | — | — | |
| SCHEMBL29078764 | 0.72 | — | — | |
| SCHEMBL22043578 | 0.72 | — | — | |
| SCHEMBL28223207 | 0.72 | — | — | |
| Hydrochloric Acid SCHEMBL29136148 | 0.70 | TSHR (0.38) | — | |
| Hydrochloric Acid SCHEMBL28566170 | 0.69 | TSHR (0.39) | — | |
| SCHEMBL19962843 | 0.69 | — | — | |
| SCHEMBL15004 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115312852-A | Polymer solid electrolyte and preparation method and application thereof | 中南大学 | 2022-11-08 | — | — | CN | claimed |
| US-4490516-A | POLYMERIZATION OF CELLULOSE ETHER OR ESTER WITH ACRYLAMIDE | A. E. STALEY MANUFACTURING COMPANY (US) | 1984-12-25 | — | — | US | claimed |
| US-20230138968-A1 | CONTACT LENS WITH OPTICAL PROPHYLAXIS | HIGH PERFORMANCE OPTICS, INC. (US) | 2023-05-04 | — | — | US | disclosed |
| US-20230063768-A1 | IMMUNOPHILIN BINDING AGENTS AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-03-02 | — | — | US | disclosed |
| CN-115312852-A | Polymer solid electrolyte and preparation method and application thereof | 中南大学 | 2022-11-08 | — | — | CN | disclosed |
| US-11208388-B2 | Certain chemical entities, compositions, and methods | NEUPHARMA, INC (US) | 2021-12-28 | — | — | US | disclosed |
| EP-3773929-A1 | METHOD FOR PRODUCING AN ENTADA SEED EXTRACT ENRICHED WITH METABOLITES OF INTEREST, EXTRACT PRODUCED BY SUCH A METHOD, AND COSMETIC AND DERMOCOSMETIC APPLICATIONS OF SUCH AN EXTRACT | Exsymol (MC) | 2021-02-17 | — | — | EP | disclosed |
| CN-107250116-B | 3, 5-diaminopyrazole kinase inhibitors | 艾士盟医疗公司 | 2020-10-27 | — | — | CN | disclosed |
| US-10703741-B2 | Covalent inhibitors of PAD4 | PADLOCK THERAPEUTICS, INC. (US) | 2020-07-07 | — | — | US | disclosed |
| WO-2019197548-A1 | METHOD FOR PRODUCING AN ENTADA SEED EXTRACT ENRICHED WITH METABOLITES OF INTEREST, EXTRACT PRODUCED BY SUCH A METHOD, AND COSMETIC AND DERMOCOSMETIC APPLICATIONS OF SUCH AN EXTRACT | EXSYMOL (MC) | 2019-10-17 | — | — | WO | disclosed |
| US-20190276432-A1 | COVALENT INHIBITORS OF PAD4 | PADLOCK THERAPEUTICS INC (US) | 2019-09-12 | — | — | US | disclosed |
| US-20190040065-A1 | EGFR Inhibitors and Methods of Treating Disorders | DANA-FARBER CANCER INSTITUTE, INC. | 2019-02-07 | — | — | US | disclosed |
| CN-106243006-A | (3 alkylthio group) acrylic acid derivative compound and cosmetic applications thereof | 爱西美有限公司 | 2016-12-21 | — | — | CN | disclosed |
| CN-105722836-A | PHARMACEUTICALLY ACCEPTABLE SALTS OF 3,5-DIAMINOPYRAZOLE KINASE INHIBITORS | 埃克希金医药品有限公司 | 2016-06-29 | — | — | CN | disclosed |
| US-4490516-A | POLYMERIZATION OF CELLULOSE ETHER OR ESTER WITH ACRYLAMIDE | A. E. STALEY MANUFACTURING COMPANY (US) | 1984-12-25 | — | — | US | disclosed |
| US-4079025-A | ADDITION POLYMER | A. E. STALEY MANUFACTURING COMPANY (US) | 1978-03-14 | — | — | US | disclosed |
| US-4060506-A | Starch acrylamides and the method for preparing the same | A. E. STALEY MANUFACTURING COMPANY (US) | 1977-11-29 | — | — | US | disclosed |